...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

NBB - I think it's more likely we see ZEL sold and money or shares or a combination there of distributed to current shareholders. ZCC would then be listed on a more recognizable exchange like the TSX or the NASDAQ for the royalty value. Since there are no royalties at this time or in the near future ZHCLF looks like what we will have for some time.

tada

Share
New Message
Please login to post a reply